Počet záznamov: 1
exenatid
SYS d000077270 LBL 00000nz--a2200181n--4500 005 20250606222642.1 008 190101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 065 $a D12.644.187 065 $a D20.888.300 065 $a D23.946.833.300 066 $a 01 $c 03 150 $a exenatid $x AA $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Bydureon $2 slo 450 $w v $a Byetta $2 slo 450 $w v $a Ex4 peptid $2 slo 450 $w v $a exendín-4 $2 slo 550 $7 sllk_us_auth*d019440 $Y Anti-Obesity Agents $w P $a látky proti obezite 550 $7 sllk_us_auth*d054795 $Y Incretins $w P $a inkretíny 550 $7 sllk_us_auth*d000097789 $Y Glucagon-Like Peptide-1 Receptor Agonists $w P $a agonisty receptora glukagónu podobného peptidu 1 665 $a 2019 (1992) $2 eng 680 9-
$i A synthetic form of exendin-4, a 39-amino acid peptide isolated from the venom of the GILA MONSTER lizard (Heloderma suspectum). Exenatide increases CYCLIC AMP levels in pancreatic acinar cells and acts as a GLUCAGON-LIKE PEPTIDE-1 RECEPTOR (GLP-1) agonist and incretin mimetic, enhancing insulin secretion in response to increased glucose levels; it also suppresses inappropriate glucagon secretion and slows gastric emptying. It is used as an anti-diabetic and anti-obesity agent. $2 eng 750 -2
$a Exenatide $2 eng 980 $x M
Počet záznamov: 1